Gingival defects can be treated in multiple ways. The current gold standard is connective tissue graft (CTG) in order to treat Class I and II Miller defects (Chambrone, 2008). One of the newer procedures is the use of platelet-rich fibrin (PRF) therapy, which involves drawing the patient’s own blood and forming a membrane to heal gingival defects. This literature review looks at scholarly articles comparing the use of PRF to CTG in healing clinical attachment loss (CAL) over a period of 6 months and whether one is more effective than the other in gaining CAL.
Author: Stephanie Tu, Dental Hygiene Class of 2020
Dental Hygiene Award Winner
Loading…
Reload document 
Open in new tab